Yoshiyama M, Roppolo J R, De Groat W C
Department of Pharmacology, University of Pittsburgh, PA 15261, USA.
Eur J Pharmacol. 1995 Dec 4;287(1):73-8. doi: 10.1016/0014-2999(95)00615-7.
In unanesthetized decerebrate rats, GYKI 52466 (1-(4-aminophenyl)-4-methyl-7,8-methylenedioxy-5H-2,3-benzodiazepine hydrochloride), an AMPA/kainate receptor antagonist, and MK-801 (dizocilpine), an NMDA receptor antagonist, acted synergistically to depress the micturition reflex. MK-801 (1 mg/kg i.v.) and GYKI 52466 (4 mg/kg i.v.) administered separately had no or only a small depressant effect on reflex bladder contractions but markedly depressed external urethral sphincter activity. However, in MK-801-treated rats, GYKI 52466 decreased the amplitude, frequency and duration of reflex bladder contractions. These results suggest that both AMPA/kainate and NMDA glutamate receptors are important in the micturition reflex pathway and that these receptors may be activated in parallel at some site in the pathway so that excitatory transmission via only one receptor type is sufficient to mediate reflex activation of the bladder.
在未麻醉的去大脑大鼠中,AMPA/海人酸受体拮抗剂GYKI 52466(1-(4-氨基苯基)-4-甲基-7,8-亚甲基二氧基-5H-2,3-苯并二氮杂䓬盐酸盐)和NMDA受体拮抗剂MK-801(地佐环平)协同作用以抑制排尿反射。单独静脉注射MK-801(1毫克/千克)和GYKI 52466(4毫克/千克)对反射性膀胱收缩无作用或仅有轻微抑制作用,但能显著抑制尿道外括约肌活动。然而,在MK-801处理的大鼠中,GYKI 52466降低了反射性膀胱收缩的幅度、频率和持续时间。这些结果表明,AMPA/海人酸和NMDA谷氨酸受体在排尿反射通路中都很重要,并且这些受体可能在该通路的某个部位同时被激活,因此仅通过一种受体类型的兴奋性传递就足以介导膀胱的反射性激活。